Healthcare Industry News: HSMN NewsFeed
News Release - April 25, 2012
Toshiba’s AIDR 3D Receives FDA ClearanceDose-Reduction Software Makes CT Exams Safer, Improves Image Quality
TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--Toshiba America Medical Systems, Inc. announces the FDA clearance of Adaptive Iterative Dose Reduction 3D (AIDR 3D), the company’s newest dose-reduction technology. Toshiba will offer the AIDR 3D software upgrade and related training, complimentary, to all existing Aquilion™ ONE, Aquilion Premium and Aquilion PRIME CT customers.
AIDR 3D is Toshiba’s third generation iterative dose reconstruction software that incorporates significant system enhancements by reducing radiation dose compared to conventional scanning. It is a sophisticated algorithm designed to work in both the raw data and image data space, reducing noise while attempting to maintain image quality.
AIDR 3D can also be seamlessly integrated with SUREExposureTM 3D, a software that calculates the minimum radiation exposure required for every exam. SUREExposure 3D adjusts the dose for each patient based on a pre-set, targeted level of image quality.
“Toshiba is constantly developing new technologies that help to improve imaging and patient care,” said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “With the introduction of AIDR 3D, Toshiba is continuing its commitment to offering advanced dose reduction technologies.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.
Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems, and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).
Source: Toshiba America Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsToshiba Medical Offers Healthcare Providers of All Sizes High Quality Ultrasound Exams with a Cost-Effective System
Toshiba Medical Introduces New Compact Solution for Advanced Ultrasound Imaging
Toshiba Medical’s Fully Integrated Model-Based Iterative CT Reconstruction Receives FDA Clearance